All Releases
 |
PPD to Present at Second Annual World Pharma Trials
Mar 15, 2010
|
9.7 KB |
|
| |
WILMINGTON, N.C. (March 15, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced Simon Britton, vice president of clinical development, Asia Pacific, is a guest speaker at the World Pharma Trials 2010 conference in Singapore. His presentation will address the effectiveness of Asia's people, infrastructure and CROs in supporting the region's...
|
|
PPD Achieves Gold WELCOA Well Workplace Designation
Mar 3, 2010
|
8.7 KB |
|
| |
WILMINGTON, N.C. (March 3, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has achieved national Gold Well Workplace designation by Wellness Councils of America (WELCOA), becoming one of only two North Carolina companies honored in 2009 for its commitment to protecting and enhancing the health and well-being of its employees.
...
|
|
PPD Declares First Quarter Dividend
Mar 1, 2010
|
8.7 KB |
|
| |
WILMINGTON, N.C. (March 1, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors declared a cash dividend for the first quarter of 2010 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. The record date for the first quarter dividend is March 15, 2010, and the payment da...
|
|
PPD Opens Contract Research Operations in Athlone, Ireland
Mar 1, 2010
|
11.0 KB |
|
| |
WILMINGTON, N.C (March 1, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has officially opened its contract research facility in Athlone, Ireland, which includes an 18,000-square-foot analytical testing laboratory and clinical supplies business. The facility expands the company's global scientific expertise, laboratory capacity and s...
|
|
PPD Announces Filing of Form 10 Registration Statement with SEC for Previously Announced Spin-off
Feb 24, 2010
|
10.0 KB |
|
| |
WILMINGTON, N.C. (February 24, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced its wholly-owned subsidiary, Furiex Pharmaceuticals, Inc., filed a Form 10 registration statement with the Securities and Exchange Commission, or SEC, in connection with its previously announced spin-off. The filing is an important milestone toward completing ...
|
|
PPD Names Lee E. Babiss Executive Vice President of Global Laboratory Services
Feb 22, 2010
|
9.8 KB |
|
| |
WILMINGTON, N.C. (February 22, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Lee E. Babiss, Ph.D., as executive vice president of global laboratory services. He will provide strategic direction and additional scientific leadership to the company's bioanalytical, cGMP and global central laboratories, vaccines and biol...
|
|
PPD Opens Offices in Manila, Philippines, and Bangalore, India
Feb 18, 2010
|
10.9 KB |
|
| |
WILMINGTON, N.C. (February 18, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced the opening of offices in Manila, Philippines, and Bangalore, India, expanding its Phase II-IV clinical development services in response to growing client demand in Asia Pacific. PPD will provide cli...
|
|
PPD's Global Central Lab in Singapore Earns CAP Accreditation
Feb 9, 2010
|
10.0 KB |
|
| |
WILMINGTON, N.C. (February 9, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced its global central lab operations in Singapore has earned accreditation by the College of American Pathologists (CAP), validating its ability to deliver high-quality, reliable ...
|
|
PPD Reports Fourth Quarter and Full Year 2009 Financial Results
Feb 8, 2010
|
98.0 KB |
|
| |
Highlights:
Completed two strategic acquisitions in China
Full year 2009 cash flow from operations of $253 million
Establishing strategic outsourcing partnerships
Planning to spin off compound partnering business by mid-2010
WILMINGTON, N.C....
|
|
PPD Celebrates 25 Years of Advancing Drug Development
Feb 2, 2010
|
10.0 KB |
|
| |
WILMINGTON, N.C. (February 2, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it is celebrating 25 years as one of the world's leading contract research organizations, building upon its strong foundation and history of helping clients deliver safe, effective medicines to patients.
Founded in 1985 as a one-person consulting...
|
|
PPD Announces Fourth Quarter and Full-Year 2009 Earnings Release, Webcast and Conference Call
Jan 25, 2010
|
8.7 KB |
|
| |
WILMINGTON, N.C. (January 25, 2010) - PPD, Inc. (Nasdaq: PPDI) will release its fourth quarter and full-year 2009 financial results on Monday, February 8, 2010, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com.
On Tuesday, February 9, 2010,...
|
|
PPD Issues 2010 Financial Guidance
Jan 19, 2010
|
24.3 KB |
|
| |
Highlights:
Single-digit net revenue growth targeted in 2010
Strong cash flow delivery expected in 2010
Compound partnering business spin-off should be completed in mid-2010
WILMINGTON, N.C. (January 19, 2010) - PPD, Inc. (Nasdaq: PPDI) today reported its projected 20...
|
|
PPD Announces 2010 Financial Guidance Webcast and Conference Call
Dec 22, 2009
|
8.7 KB |
|
| |
WILMINGTON, N.C. (December 22, 2009) - PPD, Inc. (Nasdaq: PPDI) will release its fiscal year 2010 financial guidance on Tuesday, January 19, 2010, after the market closes. The release will be available on the PPD Web site at http://www.ppdi.com.
On Wednesday, January 20, 2010, at 9 a.m. EST, PPD ...
|
|
PPD Selected as Exclusive Partner by DiabetesAmerica
Dec 17, 2009
|
10.5 KB |
|
| |
WILMINGTON, N.C. (December 17, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has entered into an exclusive alliance with DiabetesAmerica™, a provider of comprehensive diabetes care services based in Houston, Texas. Under the agreement, PPD will provide clinical research training and support to more than 20 ...
|
|
PPD Launches New Global Biostatistics Technology Infrastructure
Dec 2, 2009
|
10.5 KB |
|
| |
WILMINGTON, N.C. (December 2, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has launched a new global information technology infrastructure for analysis and reporting of clinical trial data. The biostatistics technology infrastructure (BTI) is a centralized computing platform that enhances the company's ability to deliver secure, qu...
|
|
PPD Completes Acquisition of BioDuro
Nov 30, 2009
|
9.5 KB |
|
| |
WILMINGTON, N.C. (November 30, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has completed its acquisition of BioDuro LLC, a drug discovery outsourcing company focused on integrated drug discovery programs and services.
With this acquisition, PPD now employs more than 1,400 in Asia Pacific and nearly 1,000 people in China, m...
|
|
PPD to Acquire BioDuro
Nov 18, 2009
|
11.5 KB |
|
| |
WILMINGTON, N.C. (November 18, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company that provides a broad range of integrated services to biopharmaceutical companies. The acquisition will expand PPD's drug development capabilities in China.
...
|
|
PPD and Janssen Pharmaceutica Collaborate to Develop Compounds for Treatment of Irritable Bowel Syndrome and Bacterial Infections
Nov 16, 2009
|
10.8 KB |
|
| |
WILMINGTON, N.C. (November 16, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced it has entered an agreement with Janssen Pharmaceutica N.V. to develop and commercialize two Phase II-ready therapeutic compounds, one to treat diarrhea-predominant irritable bowel syndrome (IBS-d) and the other to treat complicated skin and skin structure and...
|
|
PPD Declares Fourth Quarter Dividend
Nov 11, 2009
|
8.7 KB |
|
| |
WILMINGTON, N.C. (November 11, 2009) -- PPD, Inc. (Nasdaq: PPDI) today announced its board of directors declared a cash dividend for the fourth quarter of 2009 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. The record date for the fourth quarter dividend is December 15, 2009, and the payment...
|
|
PPD to Present at CHINATRIALS 2009
Nov 6, 2009
|
9.8 KB |
|
| |
WILMINGTON, N.C. (November 6, 2009) - PPD, Inc. (Nasdaq: PPDI) today announced Simon Britton, vice president of clinical development, Asia Pacific, will present at the CHINATRIALS 2009 Global Clinical Development Summit in Beijing on November 8-10. His panel presentation will provide insight to clinical development professionals on creati...
|
|
|
